Clinical Trial Update: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study [EARLY_Phase 1]

View source ↗

Summary

Feasibility early-phase trial evaluating induction and maintenance therapy with avelumab plus R-CHOP in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Avelumab (avelumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Austin Health | Conditions: Lymphomas Non-Hodgkin's B-Cell | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING